China has highest PD-1/PD-L1 combination immuno-oncology therapies clinical trials growth:… EP News Bureau Nov 30, 2020 Between 2017 and 2019, the number of clinical trials initiated for PD-1/PD-L1 targeted combination therapies increased…
